The global diabetic neuropathy market is on track for significant expansion in the coming years, fueled by the rising prevalence of diabetes and the need for effective management strategies. According to a recent industry report, the market, valued at USD 5.25 billion in 2022, is expected to reach USD 10.23 billion by 2030, reflecting a robust compound annual growth rate (CAGR) of...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek